John Zajecka
Psychiatry · Skokie, ILNPI 1275661399
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $45,781 of the $75,987 with a category attached, or 60.2%. 44 manufacturers reported payments, led by Johnson & Johnson at 35.1% of the total. Reporting peaked in 2019 at $20,158 and has fallen 80.7% since, to $3,893 in 2025. Among psychiatry clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 542 payments — averaging $140.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$27K
- Janssen Scientific Affairs, LLC$15K
- Alfasigma USA, Inc.$14K
- Livanova USA, Inc.$9K
- AbbVie$3K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- plus $8K from 38 others
Across 717 payments — averaging $3334.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$1M
- Genentech, Inc.$376K
- Livanova USA, Inc.$358K
- Takeda Pharmaceuticals U.S.A., Inc.$192K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$158K
- Sage Therapeutics, LLC$153K
- plus $123K from 5 others
What the payments were for
- Consulting fees$45,78160%
- Speaking & faculty fees$13,75018%
- Travel & lodging$5,0617%
- Food & beverage$11,33215%
- Education$630%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$40,455
- VNS Therapy Symmetry Model 8103 Generator$8,218
- VNS Therapy$316
- TRINTELLIX$315
- INFINITY$283
- VNS - Symmetry$142
How this compares
$75,987 in reported general payments places this provider in the 95th percentile of 1,344 psychiatry providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AuvelityDextromethorphan Hbr/Bupropion | 29 | $25,198 |
| CaplytaLumateperone Tosylate | 13 | $21,870 |
| TrintellixVortioxetine Hydrobromide | 27 | $18,840 |
| PristiqDesvenlafaxine Succinate | 11 | $9,461 |
| Icosapent Ethyl | 25 | $2,481 |
| Duloxetine Hcl | 71 | $2,127 |
| Lidocaine | 11 | $1,430 |
| Alprazolam | 55 | $1,314 |
| Gabapentin | 62 | $1,190 |
| Zolpidem Tartrate | 49 | $1,171 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 50 | $1,167 |
| Bupropion XlBupropion Hcl | 23 | $1,106 |
| Oxazepam | 15 | $1,044 |
| Dextroamphetamine Sulfate | 20 | $813 |
| Armodafinil | 16 | $800 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Axsome Therapeutics, Inc.Auvelity | $705 | $25,19829 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $1,024 | $21,87013 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $919 | $18,84027 claims |
| Almatica Pharma LLCSertraline Hcl | $441 | $32122 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,344 psychiatry providers in Illinois.
Other psychiatry in Skokie
- Mark ShukhmanSkokie$250K
- Michael FeldNorthbrook$1.1M
- Jose MontesRockford$882K
- Mitchell GlaserChicago$752K
- Roukan JazayerliOrland Park$597K
- Ming XuBourbonnais$505K
- Peter WeidenChicago$440K
- Michelle DeesChicago$289K
- Abid NazeerOak Brook$228K
- Nitin ThaparOrland Park$216K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.